Schreiber named co-editor-in-chief of cancer immunology journal
Robert Schreiber, PhD, the Alumni Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has been named a co-editor-in-chief of Cancer Immunology Research.
Vaccines may make war on cancer personal
In the near future, physicians may treat some cancer
patients with personalized vaccines that spur their immune systems to
attack malignant tumors. New research led by scientists at the School of Medicine including senior author Robert Schreiber, PhD, has brought the approach one
step closer to reality.
Schreiber gives Korsmeyer Memorial Lecture
Robert Schreiber, PhD, delivered the Stanley J. Korsmeyer Memorial Lecture in May. The annual lecture honors a beloved former Washington University medical oncologist and researcher whose groundbreaking discoveries opened new doors to understanding and treating cancer.
New center aims to use immune system to fight cancer, other diseases
A new center at the School of Medicine will help scientists use the power of the immune system to fight infections and cancers. The Center for Human Immunology and Immunotherapy Programs is part of BioMed21, Washington University’s initiative to accelerate basic science discoveries into improved diagnosis and treatment for patients.
DiPersio, Schreiber to be honored by cancer group
John DiPersio, MD, PhD, chief of the Division of Oncology at Washington University School of Medicine in St. Louis, and Robert Schreiber, PhD, director of the school’s Center for Human Immunology and Immunotherapy Programs, will be honored in April by the American Association for Cancer Research.
Three faculty elected to National Academy of Sciences
Three Washington University in St. Louis scientists are among the 84
members and 21 foreign associates elected to the National Academy of
Sciences this year. Election to the academy is considered one of the
highest honors that can be accorded a U.S. scientist or engineer.